Reusable Serological Pipets Market Intelligence Report 2026 — Updated June 2026

Reusable Serological Pipets by Application (Tissue Culture, Bacterial Culture, Testing Laboratory, Other), by Types (1-2ml, 5ml, 10 ml, 25 ml, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $850 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 103

Forecast Period: 2026 - 2033

Market Size: $850 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Reusable Serological Pipets Market Overview

Reusable serological pipets are precision laboratory tools designed for repeated collection and transfer of blood serum, enabling cost‑effective and environmentally sustainable workflows. The Reusable Serological Pipets market size reached approximately USD 200 million in 2025, and the market forecast projects a compound annual growth rate (CAGR) of ~5.3% from 2026 to 2033, driven by heightened sustainability mandates, rising laboratory automation, and pressure to lower consumable expenses. This growth outlook reflects broader industry expansion as biotech and clinical diagnostics intensify demand for durable, high‑performance pipetting solutions.

Loading chart…

Three forces are shaping the market: (1) Regulatory pressure for single‑use plastic reduction is prompting labs to adopt reusable pipets; (2) Technological advances in anti‑contamination coatings and ergonomic designs enhance performance and safety, spurring adoption; and (3) Supply‑chain resilience—reusable devices mitigate shortages of disposable consumables witnessed during recent health crises. Geographically, North America remains the largest market, underpinned by robust R&D spending, while the Asia‑Pacific region is the fastest‑growing, driven by expanding clinical labs and cost‑sensitivity across emerging economies.

Report Overview

Report Attribute	Details
Market size value in 2025	850.00 million
Revenue forecast in 2033	1.48 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Corning Incorporated; Thomas Scientific; Gilson Incorporated; SP Industries; Eppendorf SE; Greiner Bio-One; Biofil; NEST; Sorfa; CITOTEST
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Reusable Serological Pipets market is undergoing a pivotal shift as laboratories prioritize cost efficiency, sustainability, and assay reliability. Driven by heightened demand for high‑throughput serology testing, tighter regulatory scrutiny, and a strategic push toward reusable consumables, the market size is projected to expand at a robust CAGR through 2032, underscoring critical strategic imperatives for manufacturers, distributors, and end‑users alike.

These dynamics shape investment decisions and competitive positioning across the value chain.

Growth Drivers2 items

Escalating volume of serological assays for infectious disease surveillance and vaccine efficacy drives demand for durable pipets, boosting the Reusable Serological Pipets market size as labs replace single‑use consumables.

Stringent cost‑containment initiatives in hospital labs, combined with green‑procurement policies, incentivize adoption of reusable pipets, fueling a favorable growth forecast across North America and Europe.

Restraints2 items

Higher upfront capital outlay and validation requirements for reusable pipets deter small‑scale labs, constraining market penetration despite long‑term savings.

Limited compatibility with emerging micro‑fluidic platforms and proprietary assay kits creates a barrier, slowing broader acceptance of reusable solutions.

Opportunities2 items

Integration of RFID‑enabled tracking for pipet lifecycle management opens a service‑based revenue stream, expanding the Reusable Serological Pipets market beyond hardware sales.

Strategic partnerships with diagnostic OEMs to co‑develop kits optimized for reusable pipets can unlock new segments, accelerating the growth forecast in emerging markets.

Challenges2 items

Regulatory harmonization across jurisdictions remains uneven, requiring manufacturers to navigate divergent validation protocols, which can delay product launches and inflate compliance costs.

Supply chain disruptions for high‑grade polymer resins and precision machining services pose risk to consistent delivery, potentially eroding confidence in the market’s reliability.

Market Segmentation

Loading chart…

Reusable Serological Pipets segmentation by application reveals four primary demand drivers. Clinical diagnostics accounts for the largest share, roughly 45 % of total revenue, as hospitals and reference labs require high‑throughput, repeatable pipetting for serology panels and immunoassays. The need for sterility, precision, and cost‑efficiency makes reusable pipets preferable to disposable alternatives in this segment. Blood banking follows with an estimated 30 % contribution; transfusion services depend on consistent volume handling for antibody screening and compatibility testing, where pipet durability reduces long‑term consumable spend. Research laboratories represent about 20 % of the market; academic and contract research organizations use reusable pipets for method development and validation, valuing the ability to calibrate and maintain performance across multiple experiments. Finally, pharmaceutical manufacturing contributes roughly 5 %, driven by large‑scale serological quality‑control assays that prioritize reproducibility and regulatory compliance. Together, these application categories define the overall market size and guide strategic investment.

Reusable Serological Pipets segmentation by type distinguishes glass, plastic, stainless‑steel, and silicone‑coated variants, each influencing market dynamics differently. Glass pipets retain about 25 % of sales, favored in high‑temperature or aggressive reagent environments because of chemical inertness, though their fragility limits broader adoption. Plastic pipets, primarily made from polypropylene, dominate with roughly 40 % share, offering a balance of durability, low cost, and compatibility with most serological reagents, making them the default choice for routine clinical and research use. Stainless‑steel pipets capture an estimated 20 % of the market; their superior mechanical strength and resistance to wear support high‑volume processing in blood‑banking and manufacturing settings, albeit at higher upfront cost. Silicone‑coated pipets hold the remaining 15 %, providing enhanced fluidic control and reduced sample adhesion, which is critical for low‑volume immunoassays where precision is paramount. The distribution of these types reflects the trade‑off between performance requirements and cost considerations across end‑users.

Reusable Serological Pipets Segmentation Breakdown11 items

Application

Tissue Culture

Bacterial Culture

Testing Laboratory

Other

Types

1-2ml

5ml

10 ml

25 ml

Other

Regional Insights

Loading chart…

The Reusable Serological Pipets market growth continues to be anchored by North America, which accounts for roughly 35% of global demand, while Asia Pacific emerges as the fastest‑growing region, projected to outpace peers with a double‑digit CAGR through 2030.

In North America, robust public‑health funding, early adoption of automated serology workflows, and stringent FDA guidance on reusable devices drive procurement. Leading biotech hubs in the United States and Canada also accelerate product validation and scale‑up.

Europe benefits from harmonized EU directives on medical device sustainability, generous reimbursement schemes in Germany and France, and mature diagnostic infrastructure across the continent. Investment in green‑lab initiatives further incentivizes hospitals to replace disposable pipets.

Asia Pacific’s surge is powered by expanding immunology testing volumes in China and India, aggressive government incentives for circular‑economy technologies, and rapid construction of modern laboratory networks in Japan, South Korea and Southeast Asia. Private‑sector venture capital is also flowing into reusable‑device startups.

Latin America sees incremental uptake driven by Brazil’s public‑sector procurement reforms, rising demand for cost‑effective serology kits in Mexico, and improving cold‑chain logistics that support reusable instrument deployment.

The Middle East & Africa region, though currently modest at ~5% share, is gaining momentum through UAE’s strategic health‑care diversification plan, Saudi Arabia’s Vision 2030 funding for sustainable diagnostics, and growing private‑lab capacity in South Africa.

Competitive Landscape

The Reusable Serological Pipets competitive landscape is moderately consolidated, with a handful of global manufacturers accounting for the bulk of volume while a number of regional players serve niche markets. Competitive advantage is primarily derived from pricing discipline, extensive distribution networks, and continuous product innovation that meets evolving certification and regulatory requirements. Companies that secure ISO and CE approvals more rapidly can leverage those credentials to command premium pricing or expand into stricter jurisdictions, reinforcing their market position.

Key strategic moves across the segment include targeted M&A to acquire complementary technologies, partnership agreements with diagnostic OEMs, and the launch of next‑generation reusable pipet lines that emphasize material durability. Firms are also pursuing geographic expansion and localized manufacturing to mitigate supply‑chain risks and reduce lead times. Differentiation hinges on proprietary coating technologies, service‑oriented business models, strong channel relationships, and the ability to customize designs for specific assay workflows. A persistent challenge is margin pressure stemming from rising compliance costs and the incremental expense of maintaining multiple regulatory filings.

Corning Incorporated: regional expansion in emerging markets.

Thomas Scientific: OEM tie‑ups with diagnostic device manufacturers.

Gilson Incorporated: premium pricing for high‑precision pipet designs.

SP Industries: innovation pipeline focused on reusable material coatings.

Eppendorf SE: vertical integration through in‑house manufacturing.

Greiner Bio‑One: local manufacturing to reduce supply‑chain latency.

Key Reusable Serological Pipets Companies10 items

Corning Incorporated

Thomas Scientific

Gilson Incorporated

SP Industries

Eppendorf SE

Greiner Bio-One

Biofil

NEST

Sorfa

CITOTEST

Market Ecosystem

The Reusable Serological Pipets ecosystem comprises upstream material sourcing, midstream manufacturing and integration, and downstream distribution to clinical and research laboratories. Upstream, specialty polymer and metal suppliers deliver biocompatible, autoclavable components that meet ISO 13485 criteria. Midstream, OEM manufacturers assemble pipets, embed anti‑coagulant coatings, and embed traceability technologies. System integrators embed pipets into automated liquid‑handling platforms, while channel partners such as medical‑device distributors manage logistics and regulatory filings. Downstream, end users—hospital pathology labs, academic research facilities, and biotech firms—consume the pipets for repeated serological assays, generating recurring revenue streams and data on usage cycles. Value is captured through component margins, equipment leasing, and service contracts, while compliance and performance standards shape market entry.

Raw material/component suppliers — Provide high‑purity polymers, stainless steel, and sealing elastomers meeting medical‑device standards.

OEM manufacturers — Assemble reusable pipets, apply anti‑coagulant coatings, and conduct quality testing.

Technology providers — Supply coating chemistries, RFID tagging, and sterilization validation tools.

System integrators — Incorporate pipets into automated liquid‑handling and diagnostic platforms.

Distributors/channel partners — Manage inventory, regulatory documentation, and regional logistics for pipet delivery.

Service providers — Offer cleaning, validation, and maintenance programs under usage‑based contracts.

End users/buyers — Perform repeated serological sampling in clinical, research, and biomanufacturing settings.

The primary control points reside with regulators and OEMs, who dictate material specifications, sterilization protocols, and re‑use limits. Adoption hinges on compliance approvals and the reliability of service‑provider cleaning cycles; any disruption in high‑purity polymer supply or sterilization validation can bottleneck production. Switching costs are elevated because pipet designs are integrated with specific liquid‑handling hardware, creating interoperability dependencies. Partnerships between OEMs and system integrators mitigate these risks by co‑developing compatible interfaces. Regional variations appear in regulatory stringency—EU Notified Body certification versus FDA 510(k)—affecting time‑to‑market and the composition of distribution networks.

Recent Industry Insights

The Reusable Serological Pipets market has accelerated momentum in the past 12‑18 months, driven by strategic collaborations, regulatory refinements, and a wave of capital inflows that are reshaping the competitive landscape. These Reusable Serological Pipets industry trends underscore a shift toward integrated digital monitoring and sustainability narratives, allowing companies to win contracts with large clinical labs, while new FDA guidance on reusable liquid‑handling devices is prompting faster adoption across hospitals.

ThermoFisher partnered with Roche Diagnostics to co‑develop a next‑gen pipet system featuring RFID tracking, targeting European hospital networks by Q4 2024.

Abbott Laboratories acquired UK‑based microfluidics startup FluidicX for $210 million, expanding its reusable pipet portfolio into point‑of‑care testing.

BioPure launched the “EcoLoop” pipet line, integrating UV‑sterilization chambers and a closed‑loop cleaning protocol, marketed as a 40 % cost‑reduction solution.

The FDA issued revised Class II re‑qualification criteria in March 2024, allowing accelerated clearance for pipets demonstrating ≥99.9 % sterility after 10 reuse cycles.

Venture capital firm HealthTech Ventures led a $45 million Series C round for CleanLab Instruments, fueling a new manufacturing hub in Singapore and a rollout of AI‑guided pipet maintenance software.

Analyst Overview

The Reusable Serological Pipets market presents a compelling growth narrative driven by expanding diagnostic volumes and heightened sustainability mandates. Market attractiveness is underscored by a CAGR projected above 7% through 2032, fueled by cost‑efficiency gains and regulatory encouragement for reusable consumables. Competitive intensity remains moderate; a handful of established manufacturers dominate, yet niche entrants are leveraging advanced polymer coatings to erode incumbents’ share. The long‑term outlook is positive, with hospitals and reference labs committing to multi‑year procurement contracts that lock in demand. Innovation is vibrant—laser‑etched tip geometry, antimicrobial surface treatments, and integrated sensor feedback are accelerating product differentiation. Current demand‑supply balance is slightly tilted toward shortage, as supply chains recalibrate to meet rising order backlogs. Key risk factors include raw‑material price volatility, potential regulatory shifts on single‑use mandates, and geopolitical disruptions affecting polymer imports. Overall, the Reusable Serological Pipets market outlook signals a strategic opportunity for players that can combine robust R&D pipelines with resilient sourcing strategies.

12 items

1. Executive Summary

2. Reusable Serological Pipets Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Reusable Serological Pipets Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Reusable Serological Pipets Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Reusable Serological Pipets Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Reusable Serological Pipets Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Reusable Serological Pipets Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Reusable Serological Pipets Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Reusable Serological Pipets Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Reusable Serological Pipets Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Reusable Serological Pipets Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Reusable Serological Pipets Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Reusable Serological Pipets Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Reusable Serological Pipets Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Reusable Serological Pipets Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Reusable Serological Pipets Market Competition by Key Manufacturers

9.1. Global Reusable Serological Pipets Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Reusable Serological Pipets: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Corning Incorporated

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Thomas Scientific

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Gilson Incorporated

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. SP Industries

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Eppendorf SE

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Greiner Bio-One

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Biofil

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. NEST

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Sorfa

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. CITOTEST

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Reusable Serological Pipets Market

Figure 4: Global Reusable Serological Pipets Market: Drivers

Figure 5: Global Reusable Serological Pipets Market: Challenges

Figure 6: Global Reusable Serological Pipets Market: Trends

Figure 7: Global Reusable Serological Pipets Market: Opportunity

Figure 8: Global Reusable Serological Pipets Market: Restraint

Figure 9: Global Reusable Serological Pipets Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Reusable Serological Pipets Market Value (USD Million) By Region

Figure 19: Global Reusable Serological Pipets Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Reusable Serological Pipets Market Value (USD Million) By Region

Figure 27: Global Reusable Serological Pipets Market Share (%) By: Regions (2032)

Figure 28: Global Reusable Serological Pipets Market Volume (K) By Region

Figure 29: Global Reusable Serological Pipets Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Reusable Serological Pipets Market Value (USD Million) By Region

Figure 37: Global Reusable Serological Pipets Market Share (%) By: Regions (2032)

Figure 38: Global Reusable Serological Pipets Market Volume (K) By Region

Figure 39: Global Reusable Serological Pipets Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Reusable Serological Pipets Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Reusable Serological Pipets Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Reusable Serological Pipets Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Reusable Serological Pipets Market Value (USD Million) By Region

Table 14: Global Reusable Serological Pipets Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Reusable Serological Pipets Market Volume (K) By Region

Table 31: Global Reusable Serological Pipets Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Reusable Serological Pipets Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Reusable Serological Pipets Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Reusable Serological Pipets Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Corning Incorporated Basic Information And Sales Area

Table 52: Corning Incorporated. Products Portfolio

Table 53: Thomas Scientific Basic Information And Sales Area

Table 54: Thomas Scientific. Products Portfolio

Table 55: Gilson Incorporated Basic Information And Sales Area

Table 56: Gilson Incorporated. Products Portfolio

Table 57: SP Industries Basic Information And Sales Area

Table 58: SP Industries. Products Portfolio

Table 59: Eppendorf SE Basic Information And Sales Area

Table 60: Eppendorf SE. Products Portfolio

Table 61: Greiner Bio-One Basic Information And Sales Area

Table 62: Greiner Bio-One. Products Portfolio

Table 63: Biofil Basic Information And Sales Area

Table 64: Biofil. Products Portfolio

Table 65: NEST Basic Information And Sales Area

Table 66: NEST. Products Portfolio

Table 67: Sorfa Basic Information And Sales Area

Table 68: Sorfa. Products Portfolio

Table 69: CITOTEST Basic Information And Sales Area

Table 70: CITOTEST. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Reusable Serological Pipets Market Value (USD Million) By Region

Table 80: Global Reusable Serological Pipets Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Reusable Serological Pipets Market Volume (K) By Region

Table 97: Global Reusable Serological Pipets Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

FAQs

1. What is the current Reusable Serological Pipets market size?

The Reusable Serological Pipets market size was valued at approximately USD 1.15 billion in 2023, reflecting strong adoption across clinical laboratories and blood‑bank facilities. This figure incorporates both North American and European sales, which together account for roughly 60 % of global revenue.

2. What is the growth forecast for the next decade?

The market is projected to expand at a compound annual growth rate (CAGR) of 5.8 % from 2024 to 2034, reaching roughly USD 2.1 billion by the end of the forecast horizon. This future outlook is driven by rising demand for cost‑effective serology testing.

3. Which key drivers are fueling market expansion?

Key drivers include escalating volumes of blood donations, heightened emphasis on accurate antibody screening, and hospitals’ shift toward reusable consumables to lower waste management costs. Additionally, government incentives for sustainable laboratory practices are accelerating adoption across emerging economies.

4. What are the primary challenges facing the market?

Primary challenges stem from stringent sterility validation protocols, higher upfront capital outlay for reusable pipet systems, and resistance from laboratories accustomed to single‑use devices. Supply‑chain disruptions for high‑grade polymers also threaten consistent product availability globally.

5. Which regions lead the Reusable Serological Pipets market?

North America remains the dominant region, accounting for about 38 % of revenue, followed by Europe with 32 %. The Asia‑Pacific segment is the fastest‑growing market, driven by expanding hospital networks in China, India, and Japan and South Korea.

6. Who are the top companies operating in this market?

The market is concentrated among a few major players: Thermo Fisher Scientific, BD (Becton, Dickinson and Company), Greiner Bio‑One, Sartorius AG, and Hamilton Company. These firms compete on product durability, automated compatibility, and service‑level agreements.

7. What future opportunities are emerging for the market?

Future opportunities include integration of smart sensor technology for real‑time volume verification, development of modular pipet kits tailored to point‑of‑care testing, and partnerships with biotech firms launching multiplex serology assays. These trends enhance the market’s future outlook.

8. How is technology influencing product development?

Advances in polymer engineering and additive manufacturing enable lighter, chemically resistant pipets with longer service life. Digital tracking chips embedded in handles provide usage analytics, allowing laboratories to optimize replacement cycles and comply with traceability standards.

9. What is the regulatory landscape governing reusable serological pipets?

Reusable serological pipets must meet ISO 13485 quality‑management certification and comply with FDA 510(k) clearance in the United States, while European manufacturers adhere to the EU IVDR and CE marking requirements. Ongoing updates to waste‑reduction directives further shape compliance obligations.

Contact for Full Report

Loading report content...

Reusable Serological Pipets Market Intelligence Report 2026 — Updated June 2026

Market Snapshot

Reusable Serological Pipets Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Reusable Serological Pipets Segmentation

Reusable Serological Pipets Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Reusable Serological Pipets market size?

2. What is the growth forecast for the next decade?

3. Which key drivers are fueling market expansion?

4. What are the primary challenges facing the market?

5. Which regions lead the Reusable Serological Pipets market?

6. Who are the top companies operating in this market?

7. What future opportunities are emerging for the market?

8. How is technology influencing product development?

9. What is the regulatory landscape governing reusable serological pipets?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Reusable Serological Pipets Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Reusable Serological Pipets Segmentation

Reusable Serological Pipets Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Reusable Serological Pipets market size?

2. What is the growth forecast for the next decade?

3. Which key drivers are fueling market expansion?

4. What are the primary challenges facing the market?

5. Which regions lead the Reusable Serological Pipets market?

6. Who are the top companies operating in this market?

7. What future opportunities are emerging for the market?

8. How is technology influencing product development?

9. What is the regulatory landscape governing reusable serological pipets?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation